Terminated PHASE1 INTERVENTIONAL NCT00332085

Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes

Pilot Trial of Chromium-Metformin Combination in Type 2 Diabetes: Impact on Blood Sugar Control and Insulin Resistance

Sponsor: Bastyr University

Updated 5 times since 2017 Last updated: Oct 29, 2007 Started: Jan 31, 2006 Completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Issues w/recruitment

Other terminated trials from Bastyr University

Hyperthermia · Phase PHASE1 · Apr 2014

See all terminations from Bastyr University

Other Type 2 Diabetes trials with similar outcome

Browse all Type 2 Diabetes trials

This PHASE1 trial investigates Type 2 Diabetes and is currently terminated or withdrawn. Bastyr University leads this study, which shows 5 recorded versions since 2006 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE1
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE1
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE1
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE1
Jan 2017 — Jun 2018 [monthly]

Terminated PHASE1

First recorded

Jan 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bastyr University

Data source: Bastyr University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kenmore, United States
• Seattle, United States